Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
Accelerating Implementation of Long-Acting Injectables
The ALAI UP Project will support the implementation and delivery of LAI ARV at 10 demonstration sites in EHE jurisdictions in New York City (NYC) and the Southeast (SE) region of the US providing care to underserved populations and communities of color.RWHAP Technical Assistance Provider updated on 03/06/2024
-
FY24 RWHAP Part A Program Terms Report Manual
Instructions on how RWHAP Part A recipients on the RWHAP Part A PTR.Resource updated 04/03/2024
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
How to Conduct Remote Subrecipient Site Visits
Best practices and tools for conducting effective remote subrecipient monitoring. Presentation from the HRSA HIV/AIDS Bureau Division of State HIV/AIDS Programs (DSHAP) Business Day Meeting at the 2022 RWC.Resource (Conference Presentation) updated 09/14/2023
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024 -
Rapid ART Program Initiative for New Diagnoses
Rapid ART Program Initiative for New Diagnoses (RAPID) was designed to connect people with a new HIV diagnosis to ART within five days of diagnosis and within one day of their initial care visit. Linkage navigators counseled people on HIV care, identified an available clinician capable of immediately prescribing ART, scheduled the clinical appointment, and connected people to additional support services. RAPID led to a reduction in median time between initial diagnosis and both ART initiation and viral suppression.Resource from the RWHAP Best Practices Compilation updated on 03/19/2024
-
National HIV PrEP Curriculum
Online learning portal for clinicians on pre-exposure prophylaxis (PrEP) for prevention of HIV.Resource updated 03/13/2024
-
340B Drug Pricing Program
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
-
Clinical Info HIV.gov
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
-
National Clinician Consultation Center
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
-
Program and Service Monitoring Tools - Phoenix/Maricopa County EMA
Tools developed by a Part A program to monitor services and program administration.
Resource updated 09/19/2023
-
Program and Service Monitoring Tools - Cleveland/Lorain/Elyria TGA
Tools developed by a Part A program to monitor programs and services.
Resource updated 09/19/2023
-
Program and Service Monitoring Tools: New Haven EMA
Tools for site visits and program monitoring developed by a Part A program.
Resource updated 09/19/2023
-
Program and Service Monitoring Tools - Indianapolis TGA, MCHD
Tools used for quality and program monitoring by a Part A program.
Resource updated 09/19/2023
-
HIV/AIDS Guidelines
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023
-
Fiscal Monitoring Standards: Phoenix/Maricopa County
These are a series of Excel worksheets outlining standards, performance measures, and grant recipient and subrecipient responsibilities for fiscal monitoring.
Resource updated 09/19/2023